Inspyr Therapeutics, Inc. said chief medical officer Ronald Shazer resigned from his position, effective Feb. 12.
Directors Peter Grebow and Richard Buller resigned from the company's board, effective Feb. 9.
The board resignations did not result from any disagreement with the company or matter relating to its operations, policies or practices, the Westlake Village, Calif.-based drug developer said in a Feb. 14 filing with the SEC.
